PRCT - Providence announces national contract for PROCEPT Biorobotics Aquabeam Systems

• Surgical robotics firm PROCEPT BioRobotics ( NASDAQ: PRCT ) and Providence announced on Monday a multi-system, national contract to acquire AquaBeam Robotic Systems.
• The company through the acquisition hopes to partner with health systems, such as Providence to support their growing programs across the western United States.
• As of June 30, Providence hospitals had seven AquaBeam Robotic Systems installed across California and Texas.
• Aquablation therapy to treat benign prostatic hyperplasia combines real-time, multi-dimensional imaging, automated robotics and heat-free waterjet ablation for targeted, controlled and immediate removal of prostate tissue.

For further details see: